REGULATION & POLICY | NORTH AMERICA
Canada’s front-of-package nutrition rules are now mandatory, while the United States is still considering its own system. For North American food manufacturers, the bigger question is whether changing labels will ultimately lead to changes inside the package.
Key Takeaways
- Since January 1, 2026, most qualifying prepackaged foods sold in Canada that meet or exceed specified thresholds for saturated fat, sugars or sodium must display a front-of-package nutrition symbol.
- The United States has proposed, but not finalized, a federal front-of-package system that would classify saturated fat, sodium and added sugars as Low, Med or High.
- The FDA estimates that voluntary reformulation associated with its proposed rule could cost industry approximately $125 million to $377 million annually, with a primary estimate of $227 million per year over 10 years.
- Evidence from Mexico suggests some manufacturers can begin adjusting products even before a front-of-pack policy takes effect, although the largest changes in the Mexican study occurred after implementation.
- For companies operating across Canada and the U.S., front-of-package regulation is becoming a question of formulation strategy, ingredient sourcing, packaging and portfolio management, not simply label compliance.
Canada Moves From Policy to Compliance
A new regulatory divide has opened between Canada and the United States.
Canada introduced its front-of-package nutrition labelling regulations in 2022 and provided industry with a transition period ending December 31, 2025.
That transition is now over.
Since January 1, 2026, most qualifying prepackaged foods sold in Canada that contain saturated fat, sugars or sodium at or above specified thresholds have been required to display a standardized front-of-package nutrition symbol.
The black-and-white Health Canada symbol features a magnifying glass and identifies whether a food is “High in” saturated fat, sugars, sodium, or a combination of the three.
The Canadian Food Inspection Agency has stated that there is no general enforcement discretion beyond the January 1, 2026 deadline.
Products imported, manufactured in Canada or packaged at retail before January 1, however, can continue through warehouses and remain on store shelves. This means consumers may still encounter some older packaging as existing inventories move through the market.
Canada has therefore crossed an important line: front-of-package nutrition labelling has moved from regulatory preparation to marketplace implementation.
The United States has not.
North America’s Front-of-Package Regulatory Divide
| Category | Canada | United States |
|---|---|---|
| Status | Mandatory | Proposed, not final |
| Key date | Compliance date: January 1, 2026 | Proposal announced: January 14, 2025 |
| Nutrients covered | Saturated fat, sugars, sodium | Saturated fat, sodium, added sugars |
| Consumer message | “High in” | Low | Med | High |
| Label style | Black-and-white nutrition symbol with magnifying glass | Proposed “Nutrition Info” box |
| Regulatory position | Requirements are in force for qualifying products. | A federal rule has been proposed but has not been finalized. |
Canada Becomes a Real-World Test
Canada’s system is still too new to determine whether it has produced widespread reformulation across the food supply.
That distinction is important.
Products manufactured, imported or packaged before the January 1 deadline can continue moving through inventories, and rigorous before-and-after studies will require sufficient post-implementation data.
Manufacturers, however, do not necessarily need to wait for academic studies to understand the commercial calculation.
If a product narrowly exceeds Canada’s threshold for sodium, sugars or saturated fat, reducing that nutrient sufficiently could potentially change whether the front-of-package symbol is required, depending on the product and applicable regulatory threshold.
That possibility brings nutrition thresholds directly into product-development discussions alongside taste, ingredient cost, processing performance and shelf life.
The decision is no longer purely about packaging.
It can become a formulation decision.
Evidence from countries with longer experience of mandatory front-of-pack warning systems suggests that this possibility is more than theoretical.
Mexico Shows What Can Happen After Regulation Arrives
Mexico provides particularly relevant evidence.
The country announced updated mandatory front-of-pack warning requirements in March 2020, with warning labels taking effect in October that year.
Research published in PLOS Medicine on March 18, 2025 examined approximately 1,000 leading packaged foods and non-alcoholic beverages across three periods: before the policy, after its announcement and after implementation.
Researchers found reductions in at least one type of warning label across every food category studied after implementation.
Some changes were also detected during the period between announcement and implementation, providing evidence consistent with anticipatory reformulation. However, the researchers found that product reformulation occurred mainly after implementation.
The findings matter for North American manufacturers because product reformulation is rarely immediate.
A sodium-reduction project, for example, can require ingredient screening, benchtop development, sensory evaluation, shelf-life testing, plant trials, specification changes and commercial validation.
Changing a formula may also trigger procurement, packaging and regulatory work.
Companies therefore have reasons to evaluate possible reformulation before a regulatory deadline arrives.
Canada has already reached that deadline.
The U.S. remains at an earlier stage.
The U.S. Is Considering a Different Model
On January 14, 2025, the U.S. Food and Drug Administration proposed requiring front-of-package nutrition information on most packaged foods.
The proposed Nutrition Info box would provide information on three nutrients:
- Saturated fat
- Sodium
- Added sugars
Rather than Canada’s “High in” approach, the proposed American system would classify the amount of each nutrient per serving as Low, Med or High.
The distinction matters.
Front-of-package systems can communicate nutrition information in different ways, and those differences may influence how consumers interpret labels and how manufacturers respond to them.
For industry, however, one of the most revealing parts of the FDA proposal is not the label design itself.
It is the agency’s economic analysis.
FDA Is Already Accounting for Reformulation
The FDA explicitly states that reformulation is not required by the proposed rule and is not a stated goal of it.
Nevertheless, the agency’s economic analysis anticipates that some manufacturers could voluntarily reformulate products in response.
FDA estimates annualized reformulation costs over 10 years at approximately $125 million to $377 million per year, with a primary estimate of $227 million per year.
The agency separately estimates annualized relabelling costs of $66 million to $154 million, with a primary estimate of $105 million per year.
Taken together, the FDA’s primary estimates place reformulation costs at more than twice the estimated annual relabelling costs.
FDA’s Estimated Annual Industry Costs
Primary annualized estimate over 10 years
| Industry response | Estimated annual cost |
|---|---|
| Relabelling | $105 million |
| Voluntary reformulation | $227 million |
| Combined primary estimate | $333 million |
The comparison is significant.
If the rule is finalized, the FDA does not expect every manufacturer to reformulate, nor does it require them to do so. But its economic modelling recognizes that some companies could decide that changing a product makes commercial sense in response to the information displayed on the front of the package.
That turns a proposed labelling regulation into a potential R&D consideration.
Why Manufacturers May Move Before Washington Does
For U.S. manufacturers, Mexico’s experience raises an important strategic question.
How long should a company wait before beginning formulation work?
Regulatory certainty has obvious value. Reformulating against a proposal that later changes can waste time and resources.
Waiting until a final rule is issued, however, carries a different risk.
Reformulation can require months or longer, particularly when nutrient reduction affects flavour, texture, shelf life or processing performance.
Companies selling products in both Canada and the United States face another layer of complexity.
A product requiring Canada’s “High in Sodium” symbol might also receive a “High” sodium classification if a future U.S. system were finalized with criteria that capture the same product.
The thresholds and regulatory frameworks are not identical, so one country’s classification cannot simply be assumed to predict the other’s.
But the possibility creates an obvious portfolio question:
Does it make sense to maintain different formulations for different markets, or should the company develop a formulation capable of performing across both?
For multinational manufacturers, that decision involves more than nutrition science. It can affect ingredient procurement, manufacturing efficiency, packaging inventories, SKU complexity and supply-chain management.
The Reformulation Trade-Off
There is also a counterargument to early reformulation.
Changing a formulation simply to improve its front-of-package classification may not always be technically feasible, economically justified or beneficial to the overall product.
Salt, sugar and fat perform functions beyond nutrition.
Reducing sodium can affect flavour, preservation and processing behaviour. Reducing sugar can influence sweetness, bulk, browning, texture and shelf life. Changing saturated-fat content can affect mouthfeel, structure and product stability.
Replacement ingredients may also cost more.
A reformulated product that meets a regulatory target but loses consumer acceptance can create a larger commercial problem than the label it was intended to avoid.
Smaller manufacturers may face particular challenges because they often have fewer R&D resources, fewer formulation specialists and less capacity for repeated pilot and production trials.
There is therefore no universal business case for reformulation.
For some products, accepting the front-of-package designation may be more practical than changing a successful formulation.
For others, particularly products sitting close to a regulatory threshold, relatively modest formulation changes could offer a more attractive path.
That calculation will differ by product, category, market and brand positioning.
Labels Are Becoming an R&D Issue
Canada and the United States now illustrate two different points on the regulatory timeline.
Canada has moved from policy development through transition and into mandatory compliance.
The United States remains in the proposal stage.
Between those positions sits a strategic question for manufacturers: when should regulatory monitoring become product-development action?
Evidence from Mexico shows that front-of-pack policies can be associated with meaningful reformulation once implemented and that some changes may begin before implementation.
The FDA’s own economic analysis assumes voluntary reformulation could become a substantial industry response if its proposal becomes final.
For food manufacturers, that means front-of-package nutrition policy increasingly intersects with R&D, regulatory affairs, procurement, packaging and portfolio strategy.
Why It Matters
Canada is now providing North America’s first major real-world test of how a mandatory nutrient-focused front-of-package system may influence the food industry at scale.
The immediate impact is visible on packaging.
The longer-term question is what happens to the products behind those packages.
For manufacturers, the strategic challenge is not necessarily to reformulate everything. It is to identify where reformulation makes technical and commercial sense, where existing products should remain unchanged, and where future regulation could alter that calculation.
For ingredient suppliers, the shift creates opportunities in sodium reduction, sugar reduction, fat modification, taste modulation, texture management and other technologies capable of helping manufacturers reach nutritional targets without sacrificing product performance.
For U.S. companies, Canada’s experience is particularly worth watching while the FDA’s proposal remains unresolved.
Front-of-package regulation may start with the label, but its competitive consequences can reach much further inside the business.
Sources
- Health Canada. Nutrition labelling: Front-of-package nutrition symbol. Updated January 5, 2026.
- Canadian Food Inspection Agency. Front-of-package (FOP) nutrition symbol and compliance and enforcement guidance. 2025-2026.
- U.S. Food and Drug Administration. FDA Proposes Requiring At-a-Glance Nutrition Information on the Front of Packaged Foods. January 14, 2025.
- U.S. Food and Drug Administration. Food Labeling: Front-of-Package Nutrition Information (Proposed Rule). Regulatory Impact Analysis.
- Salgado JC, Pedraza LS, Contreras-Manzano A, Aburto TC, Tolentino-Mayo L, Barquera S. Product reformulation in non-alcoholic beverages and foods after the implementation of front-of-pack warning labels in Mexico. PLOS Medicine, 22(3): e1004533. Published March 18, 2025.
Leave a Reply